Literature DB >> 22920829

Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes.

Signe Schmidt, Anne Katrine Duun-Henriksen, Kirsten Nørgaard.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22920829      PMCID： PMC3440174          DOI： 10.1177/193229681200600434

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  6 in total

1.  Psychosocial factors associated with use of continuous glucose monitoring.

Authors:  M D Ritholz; A Atakov-Castillo; M Beste; E A Beverly; A Leighton; K Weinger; H Wolpert
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

2.  Real-life utilization of real-time continuous glucose monitoring: the complete picture.

Authors:  Neesha Ramchandani; Sandeep Arya; Svetlana Ten; Sonal Bhandari
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

3.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Authors:  Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

4.  Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Authors:  J Hermanides; K Nørgaard; D Bruttomesso; C Mathieu; A Frid; C M Dayan; P Diem; C Fermon; I M E Wentholt; J B L Hoekstra; J H DeVries
Journal:  Diabet Med       Date:  2011-10       Impact factor: 4.359

5.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Authors:  John C Pickup; Suzanne C Freeman; Alex J Sutton
Journal:  BMJ       Date:  2011-07-07

6.  Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Authors:  Roy W Beck; Bruce Buckingham; Kellee Miller; Howard Wolpert; Dongyuan Xing; Jennifer M Block; H Peter Chase; Irl Hirsch; Craig Kollman; Lori Laffel; Jean M Lawrence; Kerry Milaszewski; Katrina J Ruedy; William V Tamborlane
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112
  6 in total
  8 in total

Review 1.  Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

Authors:  Isabelle Steineck; Ajenthen Ranjan; Kirsten Nørgaard; Signe Schmidt
Journal:  J Diabetes Sci Technol       Date:  2016-10-06

2.  Utilization and Challenges of Continuous Glucose Monitoring in Sensor-Augmented Pump Therapy: A Patient Experience Analysis.

Authors:  Asma Deeb; Mishail Ziaullah; Mariette Akle; Kenneth Strauss
Journal:  J Diabetes Sci Technol       Date:  2018-09-21

3.  Continuous Glucose Monitoring in Type 1 Diabetes.

Authors:  Uirassu Borges; Thomas Kubiak
Journal:  J Diabetes Sci Technol       Date:  2016-05

Review 4.  Adherence to glycemic monitoring in diabetes.

Authors:  Susana R Patton
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

5.  Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use.

Authors:  Molly L Tanenbaum; Rebecca N Adams; Sarah J Hanes; Regan C Barley; Kellee M Miller; Shelagh A Mulvaney; Korey K Hood
Journal:  J Diabetes Sci Technol       Date:  2017-01-10

Review 6.  Influences on Technology Use and Efficacy in Type 1 Diabetes.

Authors:  Victoria Franklin
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

7.  Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes.

Authors:  A Deeb; H Yousef; N Al Qahtani; I Artan; S Suliman; M Tomy; L Abdulrahman; H Al Suwaidi; S Attia; N Nagelkerke
Journal:  J Diabetes Metab Disord       Date:  2019-05-09

8.  Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.

Authors:  J Lawton; M Blackburn; J Allen; F Campbell; D Elleri; L Leelarathna; D Rankin; M Tauschmann; H Thabit; R Hovorka
Journal:  BMC Endocr Disord       Date:  2018-02-20       Impact factor: 2.763
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.